JPMA Says IRA Is “Alarming,” Set to Exchange Views with PhRMA

July 21, 2023
JPMA Managing Director Sachiko Nakagawa (right) at Press Conference on July 20 The Japan Pharmaceutical Manufacturers Association (JPMA) on July 20 expressed its concerns about the potential impact of the Inflation Reduction Act (IRA) on Japanese drug makers, revealing its...read more